Danaher Corporation (0R2B.L)
USD 199.8
(1.48%)
USD 199.8
(1.48%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 23.89 Billion USD | -10.33% |
| 2022 | 26.64 Billion USD | -9.54% |
| 2021 | 29.45 Billion USD | 32.17% |
| 2020 | 22.28 Billion USD | 24.41% |
| 2019 | 17.91 Billion USD | 5.06% |
| 2018 | 17.04 Billion USD | -6.99% |
| 2017 | 18.32 Billion USD | 8.57% |
| 2016 | 16.88 Billion USD | 16.97% |
| 2015 | 14.43 Billion USD | 12.18% |
| 2014 | 12.86 Billion USD | -29.62% |
| 2013 | 18.28 Billion USD | 0.12% |
| 2012 | 18.26 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 5.74 Billion USD | -0.91% |
| 2024 Q1 | 5.79 Billion USD | -9.51% |
| 2024 Q3 | 5.79 Billion USD | 0.96% |
| 2023 Q4 | 6.4 Billion USD | -6.81% |
| 2023 FY | 23.89 Billion USD | -10.33% |
| 2023 Q1 | 7.16 Billion USD | -14.36% |
| 2023 Q2 | 7.15 Billion USD | -0.14% |
| 2023 Q3 | 6.87 Billion USD | -3.97% |
| 2022 FY | 26.64 Billion USD | -9.54% |
| 2022 Q4 | 8.36 Billion USD | 9.21% |
| 2022 Q3 | 7.66 Billion USD | -1.14% |
| 2022 Q2 | 7.75 Billion USD | 0.82% |
| 2022 Q1 | 7.68 Billion USD | -5.65% |
| 2021 Q1 | 6.85 Billion USD | 1.45% |
| 2021 Q2 | 7.21 Billion USD | 5.25% |
| 2021 Q3 | 7.22 Billion USD | 0.15% |
| 2021 Q4 | 8.14 Billion USD | 12.71% |
| 2021 FY | 29.45 Billion USD | 32.17% |
| 2020 Q3 | 5.88 Billion USD | 11.08% |
| 2020 Q4 | 6.76 Billion USD | 14.89% |
| 2020 FY | 22.28 Billion USD | 24.41% |
| 2020 Q1 | 4.34 Billion USD | -10.79% |
| 2020 Q2 | 5.29 Billion USD | 21.97% |
| 2019 FY | 17.91 Billion USD | 5.06% |
| 2019 Q4 | 4.86 Billion USD | 11.2% |
| 2019 Q3 | 4.37 Billion USD | -1.5% |
| 2019 Q2 | 4.44 Billion USD | 5.31% |
| 2019 Q1 | 4.22 Billion USD | 67.5% |
| 2018 FY | 17.04 Billion USD | -6.99% |
| 2018 Q2 | 4.98 Billion USD | 6.08% |
| 2018 Q4 | 2.51 Billion USD | -48.08% |
| 2018 Q3 | 4.85 Billion USD | -2.57% |
| 2018 Q1 | 4.69 Billion USD | -7.67% |
| 2017 Q2 | 4.51 Billion USD | 7.24% |
| 2017 Q1 | 4.2 Billion USD | -8.26% |
| 2017 FY | 18.32 Billion USD | 8.57% |
| 2017 Q4 | 5.08 Billion USD | 12.31% |
| 2017 Q3 | 4.52 Billion USD | 0.4% |
| 2016 Q2 | 4.24 Billion USD | 8.1% |
| 2016 Q1 | 3.92 Billion USD | -9.23% |
| 2016 Q3 | 4.13 Billion USD | -2.59% |
| 2016 FY | 16.88 Billion USD | 16.97% |
| 2016 Q4 | 4.58 Billion USD | 10.94% |
| 2015 FY | 14.43 Billion USD | 12.18% |
| 2015 Q4 | 4.32 Billion USD | 23.09% |
| 2015 Q3 | 3.51 Billion USD | 84.48% |
| 2015 Q2 | 1.9 Billion USD | -59.45% |
| 2015 Q1 | 4.69 Billion USD | -10.14% |
| 2014 FY | 12.86 Billion USD | -29.62% |
| 2014 Q4 | 5.22 Billion USD | 10.99% |
| 2014 Q1 | 4.66 Billion USD | -11.47% |
| 2014 Q3 | 4.7 Billion USD | 3.23% |
| 2014 Q2 | 4.56 Billion USD | -2.2% |
| 2013 Q3 | 4.66 Billion USD | -1.44% |
| 2013 Q2 | 4.73 Billion USD | 6.59% |
| 2013 FY | 18.28 Billion USD | 0.12% |
| 2013 Q1 | 4.44 Billion USD | -10.66% |
| 2013 Q4 | 5.26 Billion USD | 12.8% |
| 2012 Q4 | 4.97 Billion USD | 0.0% |
| 2012 FY | 18.26 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -6605.043% |
| Accuray Incorporated | 446.55 Million USD | -5249.893% |
| Align Technology, Inc. | 3.86 Billion USD | -518.55% |
| Elevance Health Inc. | 171.34 Billion USD | 86.057% |
| AxoGen, Inc. | 159.01 Million USD | -14924.023% |
| Boston Scientific Corporation | 14.24 Billion USD | -67.767% |
| CVS Health Corporation | 357.77 Billion USD | 93.323% |
| Cardinal Health, Inc. | 226.82 Billion USD | 89.468% |
| Centene Corporation | 141.26 Billion USD | 83.089% |
| DaVita Inc. | 12.14 Billion USD | -96.785% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 63.228% |
| Hologic, Inc. | 4.03 Billion USD | -492.76% |
| Humana Inc. | 106.37 Billion USD | 77.542% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -552.562% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | -96.438% |
| Masimo Corporation | 2.04 Billion USD | -1066.447% |
| McKesson Corporation | 308.95 Billion USD | 92.267% |
| Patterson Companies, Inc. | 6.56 Billion USD | -263.718% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | -158.214% |
| ResMed Inc. | 4.68 Billion USD | -409.893% |
| Henry Schein, Inc. | 12.33 Billion USD | -93.614% |
| Teladoc Health, Inc. | 2.6 Billion USD | -817.993% |
| Universal Health Services, Inc. | 14.28 Billion USD | -67.274% |
| Veeva Systems Inc. | 2.36 Billion USD | -910.715% |
| Baxter International Inc. | 14.81 Billion USD | -61.277% |
| Becton, Dickinson and Company | 19.37 Billion USD | -23.322% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | -235.341% |
| Stryker Corporation | 20.49 Billion USD | -16.548% |
| Medtronic plc | 32.36 Billion USD | 26.183% |